Merck KGaA, Darmstadt, Germany, a leading science and technology company, has adopted Quris’ Bio-AI clinical prediction ...

Canyon Labs, a leader in analytical & packaging lab testing and consulting for medical devices and pharmaceuticals, has ...

Tarsier Pharma, Ltd, a late-clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing ...

ProBioGen has expanded both protein and virus manufacturing at its Berlin headquarters—including the commissioning of an ...

Lifecore Biomedical Inc., a fully integrated contract development and manufacturing organization (CDMO), has entered into a ...

The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines, has entered a ...

Chime Biologics, a global CDMO, and Mabgeek, a clinical-stage innovative antibody drug development biotech, have successfully ...

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, has appointed Lori ...

Veeda Group has unveiled a new logo and brand identity— Veeda Lifesciences —reflecting the brand’s evolution from a ...

Sangamo plans to explore all options to commercialize the Hemophilia A asset.

Becomes the first subcutaneously administered PD-1 inhibitor.